SCIEX, a global leader in life science analytical technologies and operating company of Danaher Corporation , and Evosep Biosystems, a global leader in proteomics solutions, enter a reseller agreement ...

Assisted Living Locators, a leading nationwide senior placement and referral service, is going purple for the fourth annual year this June in support of Alzheimer's & Brain Awareness Month. The ...

The oncology giant will pay $1.5 billion to co-develop a BioNTech drug that targets the proteins PD-L1 and VEGF, following ...

As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its ...

Curogen, one of South Korea's leading biotechnology companies focused on nanotechnology-based treatments for autoimmune diseases, today announced a series of strategic appointments that strengthen its ...

France's Sanofi has agreed to buy U.S.-based Blueprint Medicines Corporation for up to $9.5 billion to boost its position in ...

An outbreak of Salmonella infections traced to cucumbers from Florida is growing. As of May 30, 45 people across 18 states had been infected. Sixteen ...

Sanofi plans to buy Blueprint Medicines in a deal worth more than $9 billion, expanding its immunology pipeline ...

On a positive note, ivonescimab, when used alongside chemotherapy, reduced the risk of disease progression or mortality by 48 ...

The share buy-back program is undertaken in accordance with Regulation (EU) No. 596/2014 ('MAR') and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the "Safe Harbour ...

A Phase III trial demonstrated mNEXSPIKE’s non-inferior efficacy compared with Moderna’s original COVID vaccine, Spikevax.

The French pharmaceutical giant is acquiring a Cambridge biotech and its rare immunology disease which is already approved in ...